These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8438868)

  • 21. Therapy for cryoglobulinemia secondary to hepatitis C virus: the need for tailored protocols and multiclinic studies.
    Agnello V
    J Rheumatol; 2000 Sep; 27(9):2065-7. PubMed ID: 10990213
    [No Abstract]   [Full Text] [Related]  

  • 22. MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha.
    Bauduer F
    Am J Hematol; 1996 Nov; 53(3):209. PubMed ID: 8895702
    [No Abstract]   [Full Text] [Related]  

  • 23. [Predictive factors of response to interferon-alpha treatment in chronic hepatitis C].
    Buti M; Esteban R
    Rev Esp Enferm Dig; 1997 Jul; 89(7):501-2. PubMed ID: 9303619
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatitis C infection with false negative serology in a patient with mixed cryoglobulinemic vasculitis].
    Tini GM; Wüscher V; Jeker R
    Dtsch Med Wochenschr; 2007 Mar; 132(12):616-8. PubMed ID: 17357905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
    Marcellin P; Pouteau M; Martinot M; Boyer N; Castelnau C; Benhamou JP; Erlinger S
    Gastroenterol Clin Biol; 1995 Dec; 19(12):991-1000. PubMed ID: 8729410
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cryoglobulinemia in chronic liver diseases: cause or consequence?].
    Csepregi A; Nemesánszky E
    Orv Hetil; 1997 Mar; 138(11):651-6. PubMed ID: 9102622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha.
    Hirashima N; Mizokami M; Orito E; Koide T; Itazu I; Kumada K; Sakakibara K; Kano H; Lau JY
    J Gastroenterol Hepatol; 1996 Oct; 11(10):955-8. PubMed ID: 8912134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mucocutaneous lichen planus induced by a second treatment with high-dose interferon-alpha in a patient with chronic viral hepatitis C].
    Perreard M; Constant T; Monges D; Djaghri N; Angeli-Besson C; Gerolami A
    Gastroenterol Clin Biol; 1994; 18(11):1051. PubMed ID: 7705576
    [No Abstract]   [Full Text] [Related]  

  • 30. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
    Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract]   [Full Text] [Related]  

  • 33. Recovery from hepatitis C virus-positive cryoglobulinaemic glomerulonephritis after interferon therapy.
    Mazzaro C; Faelli A; Baracetti S; Mezzoran L; Pussini E; Zorat F; Pozzato G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):601-3. PubMed ID: 10604101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Essential cryoglobulinemia].
    Pechère-Bertschi A; Schifferli JA
    Schweiz Rundsch Med Prax; 1993 Feb; 82(6):163-7. PubMed ID: 8434212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost effectiveness of interferon in chronic active hepatitis C.
    Turnbull C; Sugano D
    Med J Aust; 1994 Jul; 161(2):169; author reply 170. PubMed ID: 8028544
    [No Abstract]   [Full Text] [Related]  

  • 37. [What are the indications for interferon therapy with regard to the significance of serologic and histologic findings and laboratory data?].
    Gerken G
    Internist (Berl); 1993 Nov; 34(11):1062-5. PubMed ID: 8282492
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypothyroidism, hemolytic anemia and cryoglobulinemia in a patient with hepatitis C virus infection: efficacy of treatment with alpha-interferon].
    Castellano Higuera A; Gonzáles Reimers E; Alarcó Hernández B; Santolaria Fernández F; Rodríguez Gaspar M
    An Med Interna; 2003 Jul; 20(7):391-2. PubMed ID: 12951982
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost effectiveness of interferon in chronic active hepatitis C.
    Sallie R
    Med J Aust; 1994 Jul; 161(2):169-70. PubMed ID: 8080533
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.